These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 37940754)

  • 1. A National Survey of Physicians' Views on the Importance and Implementation of Deintensifying Diabetes Medications.
    Pilla SJ; Jalalzai R; Tang O; Schoenborn NL; Boyd CM; Bancks MP; Mathioudakis NN; Maruthur NM
    J Gen Intern Med; 2024 May; 39(6):992-1001. PubMed ID: 37940754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A National Physician Survey of Deintensifying Diabetes Medications for Older Adults With Type 2 Diabetes.
    Pilla SJ; Jalalzai R; Tang O; Schoenborn NL; Boyd CM; Golden SH; Mathioudakis NN; Maruthur NM
    Diabetes Care; 2023 Jun; 46(6):1164-1168. PubMed ID: 36800554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Qualitative Study of Perspectives of Older Adults on Deintensifying Diabetes Medications.
    Pilla SJ; Meza KA; Schoenborn NL; Boyd CM; Maruthur NM; Chander G
    J Gen Intern Med; 2023 Mar; 38(4):1008-1015. PubMed ID: 36175758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
    McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD
    J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.
    Casagrande S; Cowie CC; Fradkin JE
    J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician perspectives on de-intensifying diabetes medications.
    Genere N; Sargis RM; Masi CM; Nathan AG; Quinn MT; Huang ES; Laiteerapong N
    Medicine (Baltimore); 2016 Nov; 95(46):e5388. PubMed ID: 27861373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in National Diabetes Treatment Patterns and Trends between Older and Younger Adults.
    Pilla SJ; Segal JB; Alexander GC; Boyd CM; Maruthur NM
    J Am Geriatr Soc; 2019 May; 67(5):1066-1073. PubMed ID: 30703251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of Deintensification of Blood Pressure and Glycemic Medication Treatment Based on Levels of Control and Life Expectancy in Older Patients With Diabetes Mellitus.
    Sussman JB; Kerr EA; Saini SD; Holleman RG; Klamerus ML; Min LC; Vijan S; Hofer TP
    JAMA Intern Med; 2015 Dec; 175(12):1942-9. PubMed ID: 26502220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing use of patient-focused pharmacotherapy in glycemic management through the Diabetes Collaborative Registry (DCR).
    Arnold SV; McGuire DK; Inzucchi SE; Tang F; Mehta SN; Lam CSP; Goyal A; Sperling LS; Wong ND; Hammar N; Fenici P; Kosiborod M
    J Diabetes Complications; 2018 Nov; 32(11):1035-1039. PubMed ID: 30177468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults.
    Goyal P; Anderson TS; Bernacki GM; Marcum ZA; Orkaby AR; Kim D; Zullo A; Krishnaswami A; Weissman A; Steinman MA; Rich MW
    J Am Geriatr Soc; 2020 Jan; 68(1):78-86. PubMed ID: 31509233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deintensification of hypoglycaemic medications-use of a systematic review approach to highlight safety concerns in older people with type 2 diabetes.
    Abdelhafiz AH; Sinclair AJ
    J Diabetes Complications; 2018 Apr; 32(4):444-450. PubMed ID: 29274807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany.
    Chen J; Perez-Nieves M; Piras De Oliveira C; Spaepen E; Osumili B; Poon JL; Schloot N; Lara N; Garcia Alvarez L; Roset M
    Postgrad Med; 2020 Nov; 132(8):727-736. PubMed ID: 33108957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes.
    Levin PA; Wei W; Zhou S; Xie L; Baser O
    J Manag Care Spec Pharm; 2014 May; 20(5):501-12. PubMed ID: 24761822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with clinical inertia in type 2 diabetes mellitus patients treated with metformin monotherapy.
    Kartoun U; Iglay K; Shankar RR; Beam A; Radican L; Chatterjee A; Pai JK; Shaw S
    Curr Med Res Opin; 2019 Dec; 35(12):2063-2070. PubMed ID: 31337263
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment Dosing Patterns and Clinical Outcomes for Patients with Type 2 Diabetes Starting or Switching to Treatment with Insulin Glargine (300 Units per Milliliter) in a Real-World Setting: A Retrospective Observational Study.
    Gupta S; Wang H; Skolnik N; Tong L; Liebert RM; Lee LK; Stella P; Cali A; Preblick R
    Adv Ther; 2018 Jan; 35(1):43-55. PubMed ID: 29313285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of glucose, blood pressure, and lipid lowering medications among people with type II diabetes in the United States, 1999-2010.
    Wong HK; Ong KL; Cheung CL; Cheung BM
    Ann Epidemiol; 2014 Jul; 24(7):516-21.e1. PubMed ID: 24935464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes.
    Baru A; Amir S; Ekelund M; Montagnoli R; Da Rocha Fernandes JD
    Postgrad Med; 2020 May; 132(4):320-327. PubMed ID: 32306819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Setting the hemoglobin A1c target in type 2 diabetes: a priori, a posteriori, or neither?
    Giugliano D; Maiorino MI; Bellastella G; Petrizzo M; Ceriello A; Genovese S; Esposito K
    Endocrine; 2015 Sep; 50(1):56-60. PubMed ID: 25672778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014.
    Mahoney GK; Henk HJ; McCoy RG
    Mayo Clin Proc; 2019 Sep; 94(9):1731-1742. PubMed ID: 31422897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.